Skip to main content
. 2013 Feb 19;108(5):1052–1060. doi: 10.1038/bjc.2013.69

Figure 3.

Figure 3

Plasma vascular endothelial growth factor A (VEGF-A) concentrations by quartile.(A) Bevacizumab 7.5 mg kg−1 vs placebo and (B) bevacizumab 15 mg kg−1 vs placebo.